Back to Top Skip to main content Skip to sub-navigation

COVID-19 Vaccine Headed to NMC San Diego and NH Camp Pendleton

Image of Gloved hands preparing vaccine for transportation. Click to open a larger version of the image. The first doses of Pfizer's COVID-19 vaccine arrived at Naval Medical Center San Diego (NMCSD), with distribution being conducted in phases, Dec. 14. NMCSD and Naval Hospital Camp Pendleton (NHCP) were selected by the DOD's COVID Task Force based on recommendations from the military services and U.S. Coast Guard, to best support several criteria to include anticipated supply chain requirements, such as cold and bulk storage facilities; local population of at least 1,000 priority personnel across the military services; and sufficient medical personnel to administer vaccines and actively monitor vaccine recipients. NMCSD’s mission is to prepare service members to deploy in support of operational forces, deliver high quality healthcare services and shape the future of military medicine through education, training and research. (Photo by Navy Mass Communications Petty Officer First Class Vernishia Vaughn-Lucas.)

Recommended Content:

Coronavirus | COVID-19 Vaccine Efforts | Coronavirus and the COVID-19 Vaccine

The COVID-19 vaccine that received emergency use authorization (EUA) approval from the U.S. Food and Drug Administration (FDA) last week is headed to two military treatment facilities in Southern California.

On Monday, Dec. 14, Naval Medical Center San Diego (NMCSD) received its first shipment of the COVID-19 vaccine, some of which will be distributed to Naval Hospital Camp Pendleton (NHCP). Naval Medical Center San Diego expects to begin vaccinations Tuesday, Dec. 15 and Naval Hospital Camp Pendleton expects to begin vaccinations on Wednesday, Dec. 16. This shipment is part of the DOD allotment of vaccine and is separate from vaccine being shipped directly to State of California authorities.

In accordance with the Department of Defense’s prioritization schema for administering the vaccine, which is consistent with guidance from the Centers for Disease Control and Prevention (CDC), the first doses of the vaccine will be given to frontline health care workers and first responders, including emergency medical services personnel, security forces, and other essential personnel.

"As part of our commitment to protect the health of our people, maintain readiness, and support the national pandemic response, we are proud to support Operation Warp Speed and the Department of Defense in getting this much-needed COVID-19 vaccine to our military treatment facilities in the San Diego region,” said Navy Rear Adm. Tim Weber, commander, Naval Medical Forces Pacific. “I encourage everyone who has the opportunity to get vaccinated, to do so. This doesn’t just protect the health of individuals, it protects the health of our shipmates, our families, and our community.”

The vaccine for COVID-19 was only made available after the manufacturer demonstrated it to be safe and effective in large, phase 3 clinical trials, a requirement for receiving the FDA’s approval for an EUA. In phase 3 vaccine trials, researchers administer the vaccine to very large groups of people to confirm how effectively it prevents illness, to monitor for potential side effects, and to collect information that allows the vaccine that allows it to be used safely. Before the FDA grants approval, it reviews the data submitted by the manufacturer for all clinical trial phases.

“This is the first step in getting the COVID-19 vaccine to everyone who wants it and the end goal is reducing the risk of COVID-19 infection and its impact on our warfighters and our nation,” added Weber. “But until we enter the next phase of expanding vaccine distribution and it becomes widely available, I encourage everyone to fight complacency and continue with vital public health measures such as wearing masks, socially distancing, and washing your hands frequently.”

Naval Medical Forces Pacific (NMFP), led by Navy Rear Adm. Tim Weber, provides oversight for 11 Navy Medicine Readiness and Training Commands (NMRTC), on the West Coast and Pacific Rim that train, man, and equip medical forces, primarily in military treatment facilities. Globally, NMFP oversees eight research laboratories that deliver cutting-edge research to enhance the deployment readiness and survivability of our warfighters.

You also may be interested in...

Communication to ABA Providers Regarding Continued Temporary Authorization to Utilize Telehealth for CPT Code 97156 During the COVID-19 National Emergency

Publication
6/3/2020

TRICARE is announcing the continuation of the temporary exception to policy regarding the use of synchronous telehealth (TH) capabilities (both audio and video) for Applied Behavior Analysis (ABA) Family Adaptive Behavior Treatment Guidance services specifically during this COVID-19 pandemic.

Recommended Content:

Coronavirus | About TRICARE

Force Health Protection Guidance (Supplement 9) -Department of Defense Guidance for Deployment and Redeployment of Individuals and Units during the Novel Coronavirus Disease 2019 Pandemic

Publication
5/26/2020

This memorandum provides force health protection (FHP) deployment and redeployment guidance for Service members (including Reserve Component (RC) and National Guard members in a title 10 or title 32 duty status) and DoD civilian employees deploying within and outside the United States during the COVID-19 pandemic, consistent with references (a) and (b).

Recommended Content:

Coronavirus

Guidance for Commanders on Risk-Based Changing of Health Protection Condition Levels During the Coronavirus Disease 2019 Pandemic

Publication
5/20/2020

This memorandum provides guidance for commanders to consider when making decisions to change health protection condition (HPCON) levels as COVID-19 pandemic conditions on and adjacent to our installations begin to improve.

Recommended Content:

Coronavirus

Resuming Elective Surgical, Invasive, and Dental Procedures in Military Medical and Dental Treatment Facilities

Publication
5/19/2020

This memorandum provides guidance on how each Military Medical Treatment Facility (MTF) and Dental Treatment Facility (DTF) may resume elective medical and dental procedures.

Recommended Content:

Public Health | Coronavirus

Modification and Reissuance of DoD Response to Coronavirus Disease 2019 -Travel Restrictions

Publication
4/20/2020

All DoD Service members will stop movement, both internationally and domestically, while this memorandum is in effect. All DoD civilian personnel, and dependents of DoD Service members and DoD civilian personnel, whose travel is Government-funded will stop movement, both internationally and domestically, while this memorandum is in effect.

Recommended Content:

Coronavirus

Implementation Guidance for Presidential Memorandum, "Providing Federal Support for Governor's Use of the National Guard to Respond to COVID-19 ," Dated April 7, 2020

Publication
4/14/2020

Recommended Content:

Coronavirus

Benefits Eligibility for 32 USC 502(f) Missions

Publication
4/14/2020

A chart outlining the various Benefits Eligibility for 32 USC 502(f) Missions

Recommended Content:

Coronavirus | About TRICARE

Memorandum on Providing Federal Support for Governors' Use of the National Guard to Respond to COVID-19

Publication
4/14/2020

Recommended Content:

Coronavirus

Delegation of Authority for Reserve Component Activation Authorities during the Coronavirus Disease 2019 Response

Publication
4/10/2020

This delegation assigns to the Service Secretaries the authority to activate Reserve Component personnel and to modify their orders as needed to employ and retain them for the COVID-19 response.

Recommended Content:

Coronavirus

Authorization to Employ Military Medical Capabilities to Treat COVID-19 Patients

Publication
4/8/2020

Effective immediately, the Commander, U.S Northern Command, is authorized, as he deems necessary and appropriate, to employ military medical capabilities under his operational control to treat patients who have contracted coronavirus disease 2019 (COVID-19).

Recommended Content:

Coronavirus

Decision Memorandum on TRICARE Implementation of the "Families First Coronavirus Response Act"

Publication
4/7/2020

The Families First Coronavirus Response Act, Public Law 116-127, Division F, Section 6006(a), limits TRICARE authority to impose copayment or other cost-sharing for novel coronavirus (COVID-19) testing and related provider visits that result in orders for or administration of Food and Drug Administration (FDA) approved, cleared, or authorized diagnostic products. In order for the Defense Health Agency (DHA) to implement, the Assistant Secretary of Defense for Health Affairs (ASD(HA)) must acknowledge the self-executing authority of the statute and direct the Director, DHA, or designee, to issue guidance implementing the statutory provisions.

Recommended Content:

About TRICARE | Coronavirus

DoD Guidance on the Use of Cloth Face Coverings

Publication
4/5/2020

Effective immediately, to the extent practical, all individuals on DoD property, installations, and facilities will wear cloth face coverings when they cannot maintain six feet of social distance in public areas or work centers (this does not include in a Service member's or Service family member's personal residence on a military installation).

Recommended Content:

Coronavirus | Public Health

Policy on Accessions and Accessions Training during the COVID-19 Outbreak

Publication
4/3/2020

The Military Departments must seek ways to maximize accessions in a responsible manner to minimize a reduction in military end strength and the potential deterioration of mid-and long-term readiness and capacity.

Recommended Content:

Coronavirus

Transition of Military Medical Treatment Facilities from Military Departments to the Defense Health Agency during the COVID-19 Response

Publication
4/2/2020

The Department's MTF transition plan is conditions-based. While the transition of MTFs to DHA is continuing, the COVID-19 response requirements are impacting DHA's ability to meet all required conditions. The need for the DHA and MILDEPs to refocus efforts away from the transition to support the COVID-19 response led to questions regarding the future of MTF Transition.

Recommended Content:

Coronavirus | Military Health System Transformation

Pharmacy Guidance for Market MTFs

Publication
3/31/2020

Message to Pharmacy Beneficiaries regarding military pharmacy services during the COVID-19 pandemic.

Recommended Content:

Coronavirus | TRICARE Pharmacy Operations | About TRICARE
<< < 1 2 3 4 5 > >> 
Showing results 46 - 60 Page 4 of 5

DHA Address: 7700 Arlington Boulevard | Suite 5101 | Falls Church, VA | 22042-5101

Some documents are presented in Portable Document Format (PDF). A PDF reader is required for viewing. Download a PDF Reader or learn more about PDFs.